Blood News and Research

RSS

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy- also pioneered at Penn- for solid cancer tumors and offers a promising new strategy in the fight against cancer.

11 Jan 2022

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

In a new study, researchers determined the early immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during mild coronavirus disease 2019 (COVID-19) in rhesus macaques.

11 Jan 2022

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Women who breastfed were less likely to develop heart disease or a stroke, or die from cardiovascular disease than women who did not breastfeed, according to a meta-analysis published today in a pregnancy spotlight issue of the Journal of the American Heart Association (JAHA), an open access, peer-reviewed journal of the American Heart Association.

11 Jan 2022

Study reveals genomic regions that could help understand obesity

A new study has helped to shine light on the genetic pathways underlying obesity. The findings could help develop more personalized ways to help people maintain a healthy weight.

11 Jan 2022

Low birth weight among IVF babies unlikely to be driven by the reproductive technology

Children conceived through medically assisted reproduction are more likely to be born premature and are at greater risk of being born small than naturally conceived babies, according to new research published today by the UCL Centre for Longitudinal Studies in collaboration with the University of Utah.

11 Jan 2022

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

A team of researchers recently analyzed differential protein glyco-isoform distributions of symptomatic and asymptomatic coronavirus disease 2019 patients.

11 Jan 2022

Real-world effectiveness of three COVID-19 vaccines

Researchers from IQVIA Real-World Solutions have investigated how effective these vaccines are against severe disease.

11 Jan 2022

Long-term exposure to air pollutants may increase the incidence of COVID-19

Long term exposure to ambient air pollution may heighten the risk of COVID-19 infection, suggests research published online in the journal Occupational & Environmental Medicine.

11 Jan 2022

SARS-CoV-2 activates microglia in the brain

Researchers demonstrate that SARS-CoV-2 can infect the human microglia.

10 Jan 2022

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

A new study posted to the pre-print server medRxiv* investigated the significant immune alterations concerning SARS-CoV-2 specific innate and adaptive immunity associated with a lower BNT162b2 mRNA vaccine response in older individuals.

10 Jan 2022

Newly developed risk scores can help identify childhood obesity risk

Newly developed risk scores synthesize genetic information into an easy-to-interpret metric that could help clinicians identify young children most at risk of developing obesity.

10 Jan 2022

FQHCs have played a key role in enabling COVID-19 vaccine equity among people of color

Racial and ethnic disparities in COVID-19 cases, hospitalizations, and deaths have persisted throughout the pandemic, and improving vaccine access and uptake among the populations that are disproportionately impacted remains one of the most critical ways to stop the spread of the virus.

10 Jan 2022

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Graft-Versus-Host Disease (GVHD).

10 Jan 2022

Scientists unravel how blood cells mount the first line of defense against viruses

Scientists have just slotted into place a big piece of the puzzle that explains how our blood cells mount their first line of defense against viruses.

10 Jan 2022

Mapping regulatory T-cell populations in COVID-19 patients

In a new study, researchers used mass spectrometry to investigate changes to immune systems, in particular regulatory T-cells (Tregs), in a large cohort of moderate, severe, and critical Japanese coronavirus disease 2019 (COVID-19) patients and healthy controls.

10 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

In a new study, researchers determined three-dose messenger ribonucleic acid (mRNA) vaccinated kidney transplant recipients’ (KTRs) neutralizing responses against SARS-COV-2 variants, breakthrough coronavirus disease 2019 infection rate, and transplant rejection rate.

10 Jan 2022

Common member of the gut microbiome found to have specific preference for blood group A antigens

Researchers have discovered that a common member of the human gut microbiome has a specific preference for blood group A antigens.

10 Jan 2022

Researchers discover a potential depression biomarker and why it affects women and men differently

A team of Université Laval scientists may have discovered why severe depression affects women and men differently, according to a study published today in Nature Communications.

10 Jan 2022

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting targets to reduce heart disease risk. Fortunately, available therapies can help when combined with new approaches that address social determinants of health and other barriers to care, according to a new American Heart Association scientific statement published today in the Association's flagship journal Circulation.

10 Jan 2022

Blood News and Research

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Study reveals genomic regions that could help understand obesity

Low birth weight among IVF babies unlikely to be driven by the reproductive technology

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

Real-world effectiveness of three COVID-19 vaccines

Long-term exposure to air pollutants may increase the incidence of COVID-19

SARS-CoV-2 activates microglia in the brain

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Newly developed risk scores can help identify childhood obesity risk

FQHCs have played a key role in enabling COVID-19 vaccine equity among people of color

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

Scientists unravel how blood cells mount the first line of defense against viruses

Mapping regulatory T-cell populations in COVID-19 patients

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Common member of the gut microbiome found to have specific preference for blood group A antigens

Researchers discover a potential depression biomarker and why it affects women and men differently

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News